PRNewswire

TOKYO, Oct. 23, 2024 /PRNewswire/ — Eisai Co. Ltd (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the company will present the latest findings on its Alzheimer’s disease (AD) pipeline and research, including our dual-acting, anti-amyloid beta (Aβ) proto

Filing responds to surge in imports following AD/CVD petitions filed in June 2024 WASHINGTON, Oct. 23, 2024 /PRNewswire/ — The American Personal Transportation Vehicle Manufacturers Coalition (Coalition), represented by Wiley Rein LLP, has filed critical circumstances allegations with the U.S.

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: